albendazole (Albenza)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Charles Patrick Davis, MD, PhD
    Charles Patrick Davis, MD, PhD

    Charles Patrick Davis, MD, PhD

    Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.

Bacterial Infections 101 Pictures Slideshow

DOSING: The dosing of albendazole depends on which parasitic infection is being treated. When treating young children, tablets may be crushed or chewed and swallowed with a drink of water. Patients are advised to take albendazole with food.

Hydatid disease: Patients are treated with albendazole for 28 days followed by a 14 day albendazole free interval, for a total of 3 cycles. Dosing is based on patient weight as follows:

  • = 60 kg: 400 mg twice daily with meals
  • < 60 kg: 15 mg/kg/day given in divided doses twice daily with meals (maximum total daily dose is 800 mg)

Neurocysticercosis: Treatment duration is 8 to 30 days. Patients are generally prescribed concurrent anticonvulsant (anti-seizure) and corticosteroid therapy during the first week. Dosing is based on patient weight as follows:

  • ≥ 60 kg: 400 mg twice daily with meals
  • < 60 kg: 15 mg/kg/day given in divided doses twice daily with meals (maximum total daily dose 800 mg)

Treatment of pediatric patients: doses vary; dose should be determined by a physician with experience treating children with this drug.

DRUG INTERACTIONS: Grapefruit juice may increase in blood levels of albendazole when administered concurrently. Fosphenytoin (Cerebyx) and phenytoin (Dilantin) decrease levels of albendazole by increasing its breakdown.

PREGNANCY: There are no adequate clinical trials of albendazole administration during pregnancy. Albendazole should only be used during pregnancy if the potential benefit of treatment justifies the potential risk to the fetus. Albendazole has been classified FDA as pregnancy risk category C.

NURSING MOTHERS: It is not known if albendazole is excreted in human milk. Due to the lack of safety data, albendazole should be used cautiously during breastfeeding.

SIDE EFFECTS: Side effects which occurred with a frequency of = 1% include:

Medically Reviewed by a Doctor on 11/21/2014

Quick GuideInfectious Mononucleosis (Mono): Symptoms and Treatment

Infectious Mononucleosis (Mono): Symptoms and Treatment
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors